Dosage and adaption of dialytic treatment;Dosificación y adecuación del tratamiento dialítico

Nefrologia

Volumn 26, Issue SUPPL.8, 2006, Pages 15-21

  Maduell, F ^a   Garcia M ^a   Alcazar R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMODIALYSIS FLUID;

ARTICLE; FEMALE; HUMAN; MALE; METHODOLOGY; PRACTICE GUIDELINE; RENAL REPLACEMENT THERAPY;

FEMALE; HEMODIALYSIS SOLUTIONS; HUMANS; MALE; RENAL DIALYSIS;

EID: 38449086520     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Sargent JA: Control of dialysis by a single-pool model: the National Cooperative Dialysis Study. Kidney Int 23 (SUPL. 13): S19-S23, 1983.
2. Lowrie EG y Teehan BP: Principles of prescribing dialysis the-rapy: Implementing recomendations from the National Coo-perative Dialysis Study. Kidney Int 23 (SUPL. 13): S113-S122, 1983.
3. Gotch FA y Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study. Kidney Int 28: 526-534, 1985.
4. Owen WF II, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329:1001-6, 1993.
5. Collins AJ, Ma JZ, Umens A, Keshavian P: Urea index and others predictors of hemodiálisis patients survival. Am J Kidney Dis 23: 272-282, 1994.
6. Held PJ, Port FK, Wolfe RA, Stannard DC, Carrol CE, Daugirdas JT, Bloembergen WE, Geer JW, Hakim RM: The dose of hemodialysis and patient mortality. Kidney Int 50: 550-556, 1996.
7. Bloembergen WE, Stannard DC, Port FK, Wolfe RA, Pugh JA, Jones CA, Greer JW, Golper TA, Held PJ: Relationship of dose of hemodialysis and cause-specific mortality. Kidney Int 50: 557-565, 1996.
8. Hakim RM, Breyer J, Ismail N, Schulman G: Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 23: 661-669, 1994.
9. Harker TF, Husni L, Huang W, Lew N, Lowrie EG: Survival of hemodialysis patients in the United States is improved with greater quantity of dialysis. Am J Kidney Dis 23: 670-680, 1994.
10. Yang CS, Chen SW, Chiang CH, Wang M, Peng SJ, Kan YT: Effects of increasing dialysis dose on serum albumin and mortality in hemodialysis patients. Am J Kidney Dis 27: 380-386, 1996.
11. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G: Supervival as an index of adequacy in dialysis. Kidney Int 41: 1286-1291, 1992.
12. Eknoyan G, Levey AS, Beck GJ, Agodoa LY, Daugirdas JT, Kusec JW, Levin NW, Schulman G: Hemodialysis (HEMO) study: rationale for selection of interventions. Semin Dial 9: 24-33, 1996.
13. Daugirdas JT, Depner TA, Gotch FA, Greene T, Keshaviah P, Levin NW, Shulman G: Comparison of methods to predict equilibrated Kt/V in the HEMO pilot study. Kidney Int 52: 1395-1405, 1997.
14. Eknoyan G, Beck G, Cheung AK, Daugirdas JT, Greene T, Kusek J, Allon M, Bailey J, Delmez JA, Depner TA, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Hemodialysis (HEMO) Study Group. Effect of dialysis dose and membrane flux in maintanance hemodialysis. N Engl J Med 347: 2010-2019, 2003.
15. NKF-DOQI Hemodialysis Adequacy Work Group Memberchip. Guidelines for hemodialysis adequacy. Am J Kidney Dis 30 (SUPL. 2): S22-S63, 1997.
16. Maduell F, García-Valdecasas J, García H, Hdez.-Jaras J, Sigüenza F, Pozo C, Giner R, Moll R, Garrigós E: Validation of different methods to calculate Kt/V considering postdialysis rebound. Nephrol Dial Transplant 12: 1928-1933, 1997.
17. Peticlerc T, Goux N, Reynier AL, Bene B: A model for non invasive estimation of in vivo dialyzer performances and patient's conductivity during hemodialysis. Int J Artif Organs 16: 585-591, 1993.
18. Steil H, Kaufman AM, Morris AT, Levin NW, Polaschegg HD: In vivo verification of an automatic non invasive system for real time Kt evaluation. ASAIO 39: M348-M352, 1993.
19. Peticlerc T, Bene B, Jacobs C, Jaudon MC, Goux N;: Non-invasive monitoring of effective dialysis dose delivered to the haemodialysis patient. Nephrol Dial Transplant 10: 212-216, 1995.
20. Lowrie EG, Chertow GM, Lew NL, Lazarus JM, Owen WF: The urea {clearance × dialysis time} product (Kt) as an outcome-based measure of hemodialysis dose. Kidney Int 56: 729-737, 1999.
21. Chertow GM, Owen WF, Lazarus JM, Lew NL, Lowrie EG: Exploring the reverse J-shaped curve between urea reduction ratio and mortality. Kidney Int 56: 1872-1878, 1999.
22. Collins A, Illstrup K, Hanson G, Berkesh R, Keshavian P: Rapid high-efficiency hemodialysis. Artif Organs 10: 185-188, 1986.
23. Keshavian P, Collins A: Rapid high efficiency bicarbonate hemodialysis. ASAIO Trans 23: 17-23, 1986.
24. Port FK: Treatment time for hemodialysis. What should it be? ASAIO 43: 225-227, 1997.
25. Kjellstrand CM: Duration and adequacy of dialysis. Overview: the science is easy, the ethic is difficult. ASAIO 43: 220-224, 1997.
26. Shohat J, Boner G: Adequacy of hemodialysis 1996. Nephron 76: 1-6, 1997.
27. Lowrie EG, Lew NL: Death risk in haemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15: 458-482, 1990.
28. Shinzato T, Nakain S, Akiba T y cols.: Survival in long term haemodialysis patients: results from the Annual Survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 11: 2139-2142, 1996.
29. Gotch FA, Sargent JA, Keen MA: Whither goest Kt/V? Kidney Int 58 (SUPL. 76): S3-S18, 2000.
30. Quellhorst y cols.: Morbidity and mortality in long-term hemofiltration. ASAIO J 6: 185-191, 1983.
31. Von Albertini B, Miller JA, Gardner PW y cols.: High-flux haemodiafiltration under six hours/week treatment. Trans ASAIO 30: 227, 1984.
32. Collins A: High flux, high efficiency procedures. En: Principles and Practice of dialysis W Heinrich (ed). Baltimore: Williams and Wilkins, p. 76, 1994.
33. Grupo Cooperativo Español de Diálisis Adecuada: Evaluación de los parámetros de diálisis adecuada en hemodiálisis y en tres diferentes técnicas de hemodiafiltración. Nefrología 14: 482-488, 1994.
34. Casino FG, López T: The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transplant 11: 1574-1581, 1996.
35. Gotch FA: The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 13 (SUPL. 6): 10-14, 1998.
36. Maduell F, Navarro V, Torregrosa E, Rius A, Dicenta F, Cruz MC, Ferrero JA: Change from thrice weekly on-line hemodiafiltration to short daily on-line hemodiafiltration. Kidney Int 64: 305-313, 2003.
37. Depner T, Daugirdas J, Greene T, Allon M, Beck G, Chumlea C, Delmez J, Goth F, Kusek J, Levin N, Macon E, Milford E, Owen W, Star R, Toto R, Eknoyan G: Hemodialysis (HEMO) Study Group: Dialysis dose and the effect of gender and body sike on outcome in the HEMO Study. Kidney Int 65: 13861394, 2004.
38. Port FK, Wolfe RA, Hulbert-Shearon TE, McCullough KP, Ashby VB, Held PJ: High dialysis dose is associated with lower mortality among woman but not among men. Am J Kidney Dis 43: 1014-1023, 2004.
39. Singer MA, Morton AR: Mouse to elephant: biological scaling and Kt/V. Am J Kidney Dis 35: 306-3309, 2000.
40. Singer MA: Of mice and men and elephant: metabolic rate sets glomerular filtration rate. Am J Kidney Dis 37: 164-178, 2001
41. Traeger J, Galland R, Arkouse W, Delwari E, Fouque D: Short daily hemodialysis: a four-year experience. Dial Transpl 30: 76-86, 2001.
42. Ting GO, Kjellstrand C, Freitas T, Carrie BJ, Zarghamee S: Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis 42: 1020-1035, 2004.
43. Guía de la SEN sobre Accesos Vasculares. Nefrología 2005